MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 355 filers reported holding MEDIVATION INC in Q3 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,102,000 | -43.7% | 18,280 | -57.0% | 0.02% | -43.2% |
| Q1 2016 | $1,957,000 | +134.4% | 42,554 | +146.3% | 0.04% | +131.2% |
| Q4 2015 | $835,000 | +22.3% | 17,280 | +7.5% | 0.02% | +14.3% |
| Q3 2015 | $683,000 | -60.2% | 16,080 | +6.9% | 0.01% | -56.2% |
| Q2 2015 | $1,718,000 | -11.5% | 15,040 | 0.0% | 0.03% | -8.6% |
| Q1 2015 | $1,941,000 | +30.5% | 15,040 | 0.0% | 0.04% | +34.6% |
| Q4 2014 | $1,487,000 | +50.4% | 15,040 | +50.4% | 0.03% | +52.9% |
| Q3 2014 | $989,000 | -14.4% | 10,000 | -33.3% | 0.02% | -19.0% |
| Q2 2014 | $1,156,000 | +43.6% | 15,000 | +20.0% | 0.02% | +40.0% |
| Q1 2014 | $805,000 | +26.2% | 12,500 | +25.0% | 0.02% | +36.4% |
| Q4 2013 | $638,000 | +6.5% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $599,000 | +21.7% | 10,000 | 0.0% | 0.01% | +10.0% |
| Q2 2013 | $492,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |